FIELD: medicine.
SUBSTANCE: method involves administering fluoroquinolone-series antibiotic like Ciproflaxin at a dose of 100-250 mg twice a day during 3-5 days and non-steroid anti-inflammatory preparation of Diclophenac at a dose of 75-150 mg/day during 3-7 days are sequentially introduced in preparing patient to diagnostic examination.
EFFECT: enhanced effectiveness in increasing method sensitivity.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING SENSITIVITY OF PCR-DIAGNOSTICS OF CHLAMYDIAL UROGENITAL INFECTION IN PATIENTS WITH PRONOUNCED EXUDATIVE INFLAMMATION | 2003 |
|
RU2257897C1 |
| METHOD OF TREATING CHRONIC URETHROPROSTATITIS WITH CHLAMYS AND UREA- MYCOPLASMA ETIOLOGY | 1999 |
|
RU2140307C1 |
| METHOD OF TREATMENT OF URINOGENITAL MYCOPLASMOSIS OF DOGS | 2014 |
|
RU2557955C1 |
| METHOD OF DIFFERENTIATING BACTERIA STRAINS ACCORDING TO RIBOSOMAL RNA GENE | 2008 |
|
RU2386695C1 |
| METHOD OF DIFFERENTIATING Mycoplasma hominis BACTERIA STRAINS ACCORDING TO RIBOSOMAL RNA GENE | 2008 |
|
RU2386699C2 |
| METHOD FOR TREATMENT OF UREAPLASMIC INFECTION | 2007 |
|
RU2333013C1 |
| METHOD OF TREATMENT OF PATIENTS WITH UROGENITAL CHLAMYDIUM, UREAPLASMA AND MYCOPLASMA INFECTION | 1995 |
|
RU2137483C1 |
| KIT FOR LABORATORY DIAGNOSIS OF INFECTIONS CAUSED BY MYCOPLASMA HOMINIS AND UREAPLASMA UREALYTICUM | 2014 |
|
RU2553548C1 |
| METHOD OF TREATING CHILDREN WITH MANIFESTATION OF LINGERING JAUNDICE IN NEONATAL PERIOD | 2009 |
|
RU2432938C2 |
| METHOD FOR DETECTION OF MOST SIGNIFICANT PATHOGENS OF NON-GONOCOCCUS UROGENITAL INFECTIONS (CHLAMYDIA TRACHOMATIS, MYCOPLASMA HOMINIS, UREAPLASMA UREALYTICUM, CYTOMEGALOVIRUS, HERPES SIMPLEX I/II) IN CHILDREN BY USING METHOD OF POLYMERASE CHAIN REACTION (PCR) | 2003 |
|
RU2271003C2 |
